| Price Range 12mo avg: | $975K – $9.2M |
|---|---|
| $/sf 12mo avg: | $383.23 |
| CAP Rate 12mo avg: | 6.30% |
| NOI average: | $250,709 |
| Lease Terms: | 25yrs NNN |
| Building Size avg: | 12,000 SF |
| Lot Size avg: | 1.70+/- acres |
CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through our 7,700 retail pharmacies, more than 900 walk-in medical clinics, a leading pharmacy benefits manager with more than 65 million plan members, and expanding specialty pharmacy services, we enable people, businesses and communities to manage health in more affordable, effective ways.
- Headquartered in Woonsocket, RI
- Largest pharmacy health care provider in the U.S.
- Integrated offerings across the spectrum of pharmacy care
- Approximately 200,000 employees in 46 states, the District of Columbia and Puerto Rico
- Information systems development office in Northern Ireland and a retail drugstore chain in Brazil
| S&P Credit Rating: | BBB+ |
|---|---|
| Moody’s Credit Rating: | Baa1 |
| Annual Revenue 2014: | $139.4B |
| Annual Revenue 2013: | $126.7B |
| Revenue Growth: | ↑ 9.90% from 2013 |
| Net Income | $4.6B |
| Units (Dec. 2014) | 7,839 |
| Average Units Volume: | $17.8M |
Yahoo! Finance: CVS News Latest Financial News for CVS
-
Broadway restaurant closed, site to be redeveloped
on December 13, 2019 at 7:35 pm
A longstanding fast food restaurant at Preston and Broadway in downtown Louisville will soon be removed. CVS Health Corp. has scooped up several parcels in the 400 block of East Broadway where it is planning to construct a nearly 10,000-square-foot pharmacy and retail store, according to plans filed with Louisville Metro Government. The filings state that the roughly 9,600-square-foot store will be located at 400 E. Broadway, where a Long John Silver’s restaurant has long resided. […]
-
UPDATE 1-CVS to increase genetic testing for some cancer patients
on December 12, 2019 at 4:47 pm
CVS Health Corp said on Thursday it will make it easier for patients with advanced cancer enrolled in some Aetna insurance plans to receive broad genetic gene sequencing tests that can help identify the best drug or treatment for them. CVS has been running an oncology program in 12 states in which patients prescribed treatment regimens that follow National Comprehensive Cancer Network guidelines automatically receive prior authorization approval, speeding the time to starting their treatment. It will now add easier access to broad-panel gene sequencing tests to that program for patients in its at-risk Aetna plans, Alan Lotvin, CVS' chief transformation officer, said in an interview. […]
-
Target CEO: We are taking 'enormous' market share in cosmetics
on December 12, 2019 at 4:37 pm
Target CEO Brian Cornell talks with Yahoo Finance about the company's success down the cosmetics aisle. […]
-
CVS Health Announces $750K in New Funding for California Harm Reduction Coalition
on December 12, 2019 at 4:00 pm
As part of its commitment to building healthier communities, CVS Health (NYSE: CVS) today announced it will be providing $750,000 over the next three years to the national Harm Reduction Coalition to improve the health and wellness of California residents impacted by prescription opioid misuse and abuse. […]
-
CVS Health Launches Transform Oncology Care™ Program to Help Improve Patient Outcomes and Lower Overall Costs
on December 12, 2019 at 1:30 pm
CVS Health (NYSE: CVS) today announced Transform Oncology Care™, anchored on a first-of-its-kind precision medicine strategy for payors. The program uses genomic testing results at the point-of-prescribing to help patients start on the best treatment, faster and in addition, matches eligible patients to clinical trials. Transform Oncology Care also uses the Company's local footprint and unique assets to improve patient outcomes and lower overall costs at every point of the cancer care journey. […]
NYSE: CVS
